CRNX
Crinetics Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$37.49
+0.98 ▲ +2.68%
🌙 3월 13일 7:16 PM ET (한국 3/14 08:16)
$37.50
+0.01 ▲ +0.03%
| Index | RUT | P/E | - | EPS (ttm) | -4.94 | Insider Own | 6.76% | Shs Outstand | 0.10B | Perf Week | -1.94% |
| Market Cap | 3.93B | Forward P/E | - | EPS next Y | 13.3% | Insider Trans | -0.73% | Shs Float | 0.10B | Perf Month | -21.26% |
| Enterprise Value | 2.95B | PEG | - | EPS next Q | -1.21 | Inst Own | 104.1% | Short Float | 14.5% | Perf Quarter | -21.99% |
| Income | -0.47B | P/S | 509.79 | EPS this Y | 3.69% | Inst Trans | 3.13% | Short Ratio | 11.71 | Perf Half Y | 11.15% |
| Sales | 0.01B | P/B | 3.61 | EPS next 5Y | 20.7% | ROA | -32.52% | Short Interest | 14.16M | Perf YTD | -19.46% |
| Book/sh | 10.38 | P/C | 3.82 | EPS past 3/5Y | -16.2% -15.33% | ROE | -40.17% | 52W High | -35.35% ($57.99) | Perf Year | 6.99% |
| Cash/sh | 9.82 | P/FCF | - | Sales past 3/5Y | 17.56% - | ROIC | -45% | 52W Low | 55.56% ($24.10) | Perf 3Y | 110.74% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -33.52% | Gross Margin | 35.47% | Volatility(W/M) | 4.36% 5% | Perf 5Y | 121.44% |
| Dividend TTM | - | EV/Sales | 382.6 | Sales Y/Y TTM | - | Oper. Margin | -6714.77% | ATR (14) | 2.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.3 | EPS Q/Q | -46.61% | Profit Margin | -6046.22% | RSI (14) | 29.17 | Recom | 1.07 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.32 | Sales Q/Q | - | SMA20 | -8.31% ($40.89) | Beta | 0.28 | Target Price | $83.5 |
| Payout | - | Debt/Eq | 0.05 | Earnings | 2000000 | SMA50 | -19.98% ($46.85) | Rel Volume | 0.79 | Prev Close | $36.51 |
| Employees | 594 | LT Debt/Eq | 0.04 | EPS/Sales Surpr. | 4.3% 37.22% | SMA200 | -5.19% ($39.54) | Avg Volume(3M) | 1.21M | Price | $37.49 |
| IPO | 2018/7/18 | Option/Short | Yes/Yes | Trades | 13539 | Volume | 956,535 | Change | 2.68% |
뉴스 로딩 중...